Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

Genzyme Europe BV

Home Clinical Trial Sponsors and OrganizationsGenzyme Europe BV

Genzyme Europe BV

ACTIVE

Netherlandswww.sanofi.nlSubsidiary

Part of 赛诺菲安万特

Share to Twitter Share to Facebook Share to LinkedIn Share to Reddit

Clinical Trials

100

78 active

Approvals

3

Total approvals

Agencies

1

Regulatory bodies

Founded

N/A

Overview

Trial Phase Distribution

Phase

Trials

Share

Phase 1

29

29.0%

Phase 2

9

9.0%

Phase 3

8

8.0%

Not Applicable

1

1.0%

Phase 4

1

1.0%

Trial Status Distribution

Active, not recruiting

76

76.0%

Completed

19

19.0%

Not yet recruiting

2

2.0%

Recruiting

2

2.0%

Withdrawn

1

1.0%

Clinical Trials

Trials sponsored by this organization (100)

A Study of the Safety and Efficacy of Two Different Regimens of Mipomersen in Patients With Familial Hypercholesterolemia and Inadequately Controlled Low-Density Lipoprotein Cholesterol

Active, not recruiting

Feb 2012480 participants

A Multicenter, Multinational, Open-Label Study of the Effects of Aldurazyme(laronidase) Treatment on Lactation in Women with Mucopolysaccharidosis I (MPS I) and Their Breastfed Infants - ND

Active, not recruiting

Dec 201010 participants

A Phase 1/2 Combined Dose Ranging and Randomised, Open-label, Comparative Study of the Efficacy and Safety of Plerixafor in Addition to Standard Regimens for Mobilisation of Haematopoietic Stem Cells into Peripheral Blood, and Subsequent Collection by Apheresis, Versus Standard Mobilisation Regimens Alone in Paediatric Patients, Aged 2 to < 18 Years, with Solid Tumours Eligible for Autologous Transplants - ND

Active, not recruiting

Dec 201067 participants

A Combined Study in Pediatric Cancer Patients for Dose Ranging and Efficacy/Safety of Plerixafor Plus Standard Regimens for Mobilization Versus Standard Regimens Alone

Active, not recruiting

Aug 201070 participants

SUMMIT Extension Study

Active, not recruiting

Jul 2010142 participants

A Study of Genz-112638 in Patients With Gaucher Disease (ENGAGE)

Feb 201028 participants

A Multicenter, Multinational Study of the Effects of Fabrazyme® (agalsidase beta) Treatment on Lactation and Infants - Effects of Fabrazyme Treatment on Lactation and Infants

Active, not recruiting

Feb 201010 participants

A Phase 3, Randomized, Multi-Center, Multi-National, Open-Label, Active Comparator Study to Evaluate the Efficacy and Safety of Genz-112638 in Patients with Gaucher Disease Type 1 who have been Stabilized with Cerezyme - ENCORE

Active, not recruiting

Dec 200996 participants

Page 1 of 13

Approvals

Approvals by Agency

SFDA

Saudi Food and Drug Authority

3

Approvals

Recent Approvals

MOZOBIL 24mg/1.2ml solution for injection

MYOZYME 50mg Powder For Concentrate For Solution For Infusion

News

No news articles found

On this page

Overview
Clinical Trials100
Approvals3
News

Back to Organizations